XML 51 R40.htm IDEA: XBRL DOCUMENT v3.21.1
Collaborative and Licensing Agreements - Revenue Recognition (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Revenue recorded $ 33,965 $ 32,385
Deferred revenue 77,800 46,200
Research collaboration    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Revenue recorded 14,800 1,000
Milestone    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Revenue recorded 12,500 12,500
Licensing    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Revenue recorded   15,600
Royalty    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Revenue recorded 6,700 3,300
Aimmune    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Revenue recorded   9,600
Alexion    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Revenue recorded 5,300 3,300
Astellas    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Revenue recorded   300
Genentech    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Revenue recorded 200 700
Gilead    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Revenue recorded   6,000
Janssen    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Revenue recorded 14,600  
MorphoSys    
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]    
Revenue recorded $ 13,900 $ 12,500